Bristol Myers Squibb Co (BMY)
Bristol Myers doesn't have much modesty when it describes what it does: its drugs and other health care products "extend and enhance human life." Very ambitious. The New York-based company makes products ranging from anti-psychotics to infant formula.
JennyB thinks if Bristol Myers Squibb Co were a catch phrase, it would be Yadda, yadda, yadda.
Bryan thinks if Bristol Myers Squibb Co were a Hostess cake, it would be a Ho Ho.
During times of high volatility and market turmoil, I recommend industries with constant demand. An example of this would be the pharmaceutical industry, focusing specifically on Bristol-Myers Squibb Co. (BMY). BMY, like the rest of the market, took a big hit in October. While most companies are still caught in a whirlwind, Bristol-Myers Squibb has already climbed back to within 10% of it's six month high. In addition to this resurgence, BMY is consistently making dividend payments to shareholders. Purchase BMY for their stability, potential long term growth, cheap price, and successive divided payments -Mike
is there any other potential breakthroughs set to come out of the pharmaceuticals in the near future?- about 3 years ago
I also like Merck in this sector. Several ground-breaking drugs close to gaining FDA approval.- about 3 years ago
Events
-
February152012Bristol-Myers Squibb Company Presents at Leerink Swann LLC's 2012 Global Healthcare Conference, Feb-15-2012
-
March192012Bristol-Myers Squibb Company Presents at EBD Group AG's BIO-Europe Spring 2012, Mar-19-2012
-
May 72012Bristol-Myers Squibb Company Presents at Deutsche Bank Securities' 37th Annual Health Care Conference, May-07-2012
-
May152012Bristol-Myers Squibb Company Presents at BofA Merrill Lynch 2012 Health Care Conference, May-15-2012
-
January242013Bristol-Myers Squibb Company expected to report Fiscal Year 2012 results on January 24, 2013. This event was calculated by Capital IQ (Created on January 27, 2012).
Members who own this company also own
Current price per share
Today's gain: $-0.12 (-0.37%)
